Although the difference in cfDNA levels were not statistically significant between healthy volunteers (M:174 ng/ml, R:66–317), patients with benign breast disease (M:181 ng/ml, R:98–295), DCIS (M:221 ng/ml R:178–513) and early BC (M:297 ng/ml, R:279-320 ng/ml) an increasing trend in the cfDNA concentration was observed (Supplementary Fig.
← all excerpts
Identification and validation of plasma biomarkers for diagnosis of breast cancer in South Asian women.
1
—
—